Emerging Non-Opioid Pharmaceuticals for Pain Management, 2020: Focus on Neuropathic Pain, Migraine, Post-Surgical Pain, Cancer Pain, Chronic Pain
Sep 22, 2020, 13:15 ET
DUBLIN, Sept. 22, 2020 /PRNewswire/ -- The "Emerging Non-Opioid Pharmaceuticals for Pain Management" report has been added to ResearchAndMarkets.com's offering.
The research provides technological advances and insights across non-opioid pharmaceuticals for the management of pain. Key application areas explored in the research include neuropathic pain, migraine, post-surgical pain, cancer pain, chronic pain, and migraine.
The research encompasses technological advances across Nav1.7 inhibitors, Calcitonin Gene-related peptide inhibitors, Platelet-rich plasma therapy, Ditans, Hydrogel therapy, and stem cell therapy among several others. The research also provides competitive intelligence across emerging innovators in this space, while providing insights across the patent landscape for non-narcotic pain therapy.
Key Topics Covered:
1. Executive Summary
1.1 Key Findings
1.2 Analysis Framework: The Publisher's Core Value
1.3 Research Methodology
2. Technology Landscape and Trends
2.1 Global Non-opioid Market
2.2 NSAIDs Continue to be Important for Pain Treatment
2.3 Types of Non-opioid Pharmaceuticals
2.4 Categories of Non-opioids in Development for Pain Management
2.4.1 Recently Approved Monoclonal Antibodies for Pain Management
2.5 Emerging Non-opioid Analgesics
2.6 Advanced Academic Researches in Pain Therapy
3. Innovation Radar
3.1 Innovation Radar of Emerging Technologies
3.2 Summary of the Scoring Methodology
3.2.1 QBioMed
3.2.2 Centrexion Therapeutics
3.2.3 Concentric Analgesics
3.2.4 Xenon Pharmaceuticals
3.2.5 KinetaBio
3.2.6 Navega Therapeutics
3.2.7 Tetra Biopharma
3.2.8 Vapogenix
4. Growth Opportunities
4.1 Pain Therapy Innovations Roadmap
4.2 Growth Opportunity 1: R&D Investment
4.3 Growth Opportunity 2: Technology Convergence
4.4 Conclusion
5. Patent Analysis
5.1 IP Overview in Non-opioid Pharmaceuticals
5.2 Leading Pharmaceutical Patent Holders
5.3 Patent Scenario
5.3Patent Scenario
6. Appendix
6.1 List of Non-opioids in the Market
6.2 Key Industry Contacts
6.3 Legal Disclaimer
Companies Mentioned
- Centrexion Therapeutics
- Concentric Analgesics
- KinetaBio
- Navega Therapeutics
- QBioMed
- Tetra Biopharma
- Vapogenix
- Xenon Pharmaceuticals
For more information about this report visit https://www.researchandmarkets.com/r/7rving
Research and Markets also offers Custom Research services providing focused, comprehensive and tailored research.
Media Contact:
Research and Markets
Laura Wood, Senior Manager
[email protected]
For E.S.T Office Hours Call +1-917-300-0470
For U.S./CAN Toll Free Call +1-800-526-8630
For GMT Office Hours Call +353-1-416-8900
U.S. Fax: 646-607-1907
Fax (outside U.S.): +353-1-481-1716
SOURCE Research and Markets
